Bamco Inc Bio N Tech Se Transaction History
Bamco Inc
- $32.9 Billion
- Q1 2025
A detailed history of Bamco Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Bamco Inc holds 7,675 shares of BNTX stock, worth $820,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,675
Previous 20,936
63.34%
Holding current value
$820,380
Previous $2.39 Million
70.73%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$872 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$455 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$433 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$203 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$193 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...